Rabab Alhazmi

Market Access Manager - Oncology & Hematology at Stemline Therapeutics Inc - New York, NY, US

Rabab Alhazmi's Contact Details
HQ
646-502-2310
Location
Riyadh,Riyadh Province,Saudi Arabia
Company
Stemline Therapeutics Inc
Rabab Alhazmi's Company Details
Stemline Therapeutics Inc logo, Stemline Therapeutics Inc contact details

Stemline Therapeutics Inc

New York, NY, US • 100 - 249 Employees
BioTech/Drugs

Stemline is a commercial-stage biopharmaceutical company committed to applying our scientific leadership and commercial expertise to transform the lives of patients with cancer.ELZONRIS a targeted therapy directed to CD123, is FDA-approved and commercially available in the U.S. for the treatment of adult and pediatric patients, two years and older, with BPDCN. In Europe, a marketing authorization application (MAA) is under review by the European Medicines Agency (EMA).Inspired by the goal to improve outcomes for patients with unmet medical needs, Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer. Currently our clinical-stage product candidates in include ELZONRIS, SL-701 and SL801.

B2B Biotechnology Healthcare Marketing Medical Diagnostics Pharmaceuticals BioTech/Drugs Commercial Physical Research
Details about Stemline Therapeutics Inc
Frequently Asked Questions about Rabab Alhazmi
Rabab Alhazmi currently works for Stemline Therapeutics.
Rabab Alhazmi's role at Stemline Therapeutics is Market Access Manager - Oncology & Hematology.
Rabab Alhazmi's email address is ***@bayer.com. To view Rabab Alhazmi's full email address, please signup to ConnectPlex.
Rabab Alhazmi works in the Research industry.
Rabab Alhazmi's colleagues at Stemline Therapeutics Inc are James Putz, Taylor Yonjof, Shawn Pack, Hanna Wohleking, Christopher James, Cidney Choi, Jared Pendergrass and others.
Rabab Alhazmi's phone number is 646-502-2310
See more information about Rabab Alhazmi